Effects of percutaneous coronary intervention on dyspnea in stable coronary artery disease

被引：0
|
作者：
Michael Wester
Franziska Koll
Mark Luedde
Christoph Langer
Markus Resch
Andreas Luchner
Karolina Müller
Florian Zeman
Michael Koller
Lars S. Maier
Samuel Sossalla
机构：
[1] University Heart Centre Regensburg,Department of Internal Medicine II
[2] University Medical Center Regensburg,Department of Internal Medicine I
[3] University Hospital Regensburg,Department of Cardiology
[4] Kardiologische Gemeinschaftspraxis Bremerhaven,Centre for Clinical Studies
[5] Kardiologisch-Angiologische Praxis,undefined
[6] Heart Centre Bremen,undefined
[7] St. Josef Hospital,undefined
[8] Hospital Barmherzige Brüder Regensburg,undefined
[9] University Hospital Regensburg,undefined
来源：
Clinical Research in Cardiology | 2023年 / 112卷
关键词：
PCI; Stable CAD; QoL; PLA-pCi-EBO; Dyspnea;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1194 / 1203
页数：9
相关论文
共 50 条
  • [21] Medical Therapy Versus Percutaneous Coronary Intervention for Patients With Stable Coronary Artery Disease
    Arbab-Zadeh, Armin
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2009, 53 (06) : 528 - 529
  • [22] Is There a Difference in Efficacy of Percutaneous Coronary Intervention for Focal and Diffuse Stable Coronary Artery Disease?
    Raharjo, Daniell Edward
    Kunadian, Vijay
    CIRCULATION-CARDIOVASCULAR INTERVENTIONS, 2021, 14 (08) : 819 - 822
  • [23] Predictors of angina resolution after percutaneous coronary intervention in stable coronary artery disease
    Verreault-Julien, Louis
    Bhatt, Deepak L.
    Jung, Richard G.
    Di Santo, Pietro
    Simard, Trevor
    Avram, Robert
    Hibbert, Benjamin
    CORONARY ARTERY DISEASE, 2022, 33 (02) : 98 - 104
  • [24] The Utilization of Stress Tests Prior to Percutaneous Coronary Intervention for Stable Coronary Artery Disease in Taiwan
    Yang, Ho-Pang
    Hung, Guang-Uei
    Lin, Cheng-Li
    Shen, Thau-Yun
    Chen, Chien-Cheng
    Niu, Ya-Lei
    Kao, Chia-Hung
    ACTA CARDIOLOGICA SINICA, 2019, 35 (02) : 111 - 117
  • [25] COURAGE or FAME ... ? Who should have percutaneous coronary intervention in stable coronary artery disease?
    Fox, Keith A. A.
    HEART, 2013, 99 (07) : 442 - 444
  • [26] Medical Therapy Versus Percutaneous Coronary Intervention for Patients With Stable Coronary Artery Disease Reply
    Schoemig, Albert
    Kastrati, Adnan
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2009, 53 (06) : 529 - 529
  • [27] A Targeted Approach to Reducing Overutilization: Use of Percutaneous Coronary Intervention in Stable Coronary Artery Disease
    Behnke, Lisa M.
    Solis, Amanda
    Shulman, Stephanie A.
    Skoufalos, Alexis
    POPULATION HEALTH MANAGEMENT, 2013, 16 (03) : 164 - 168
  • [28] Residual inflammatory status in patients with stable coronary artery disease undergoing percutaneous coronary intervention
    Kalkman, Deborah
    Aquino, Melissa
    Baber, Usman
    Guedeney, Paul
    Sorrentino, Sabato
    Vogel, Birgit
    Claessen, Bimmer
    Giustino, Gennaro
    Sweeny, Joseph
    Kovacic, Jason
    Vijay, Pooja
    Barman, Nitin
    Kini, Annapoorna
    Sharma, Samin
    Dangas, George
    Mehran, Roxana
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 72 (13) : B342 - B342
  • [29] Percutaneous coronary intervention prevents spontaneous myocardial infarction in patients with stable coronary artery disease
    Shah, Rahman
    Labroo, Ajay
    Davis, Donnie A.
    Nasr, Abrar
    Rashid, Abdul
    Le, Francis K.
    CORONARY ARTERY DISEASE, 2022, 33 (04) : 331 - 332
  • [30] A randomised study of dabigatran in elective percutaneous coronary intervention in stable coronary artery disease patients
    Vranckx, Pascal
    Verheugt, Freek W. A.
    de Maat, Moniek P.
    Ulmans, Victor A. W. M.
    Regar, Evelyn
    Smits, Peter
    ten Berg, Jurrien M.
    Lindeboom, Wietze
    Jones, Russel L.
    Friedman, Jeffrey
    Reilly, Paul
    Leebeek, Frank W. G.
    EUROINTERVENTION, 2013, 8 (09) : 1052 - 1060
12345